, a sustained drug release, as well as enhanced killing efficiency of cancer cells at low dosage. These findings are expected to inspire strategies and pave a way for utilizing PDA for constructing organic-inorganic composite nanocarriers.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: